Copertina

Beta-variant recombinant SARS CoV-2 vaccine induces durable cross-reactive antibodies against Omicron BA variants

Salvato in:
Pubblicato in:Communications Medicine vol. 5, no. 1 (Dec 2025), p. 21
Pubblicazione:
Springer Nature B.V.
Soggetti:
Pfizer Inc
Population
Severe acute respiratory syndrome
COVID-19 vaccines
Hypothesis testing
Antibodies
Hypotheses
Coronaviruses
Statistical analysis
Accesso online:Citation/Abstract
Full Text
Full Text - PDF
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!